U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06881498) titled 'A Substudy of the Effect of Acute Normovolemic Hemodilution in Bone Tumor Surgery' on March 12.
Brief Summary: The prevention of perioperative anemia has the potential to reduce complications, hospital stays, and long-term prognosis in patients undergoing bone tumor surgery. Data from previous studies suggest that the clinical efficacy of acute normovolemic hemodilution (ANH) has always been controversial, and intraoperative fluid administration strategy is an important confounding factor. The HEAL trial will assess whether ANH will improve postoperative hemoglobin levels when applying goal-directed fluid therapy in patients underg...